Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

We think that PORTOS could be used to help guide radiation dose-escalation and de-escalation in both the post-operative and definitive settings,” said Shuang (George) Zhao, MD.

After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.

“In addition, prior postoperative radiation may have treated residual pelvic [prostate cancer] and select for ... PSMA PET/CT at PSA < 0.5 ng/mL for salvage treatment planning,” they concluded.

The first patient has been enrolled in the PROSTATE-IQ trial of ArteraAI, a multimodal artificial intelligence biomarker test ...

In the study cohort, 2,310 patients died during a median follow-up of 6.3 years, and prostate cancer accounted for 454 (19.7% ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels.

SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Arjun Pon Avudaiappan discussing survival ...